Clinical trials
Observational Recurrence trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| Celgene | 1 |
| City of Hope Medical Center | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
| Eisai Co., Ltd. | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Stomach Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Duodenal Ulcer | 1 |
| Esophageal Neoplasms | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
| Lymphoma, T-Cell, Peripheral | 1 |
| Mesothelioma, Malignant | 1 |
| Multiple Myeloma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.